Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours

NCT01859351 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated for business reasons

Conditions

Advanced Solid Tumours

Interventions

DRUG: WX-037
DRUG: WX-554

Sponsor

Heidelberg Pharma AG